ATRC AtriCure Inc

Price (delayed)

$80.17

Market cap

$3.66B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.12

Enterprise value

$3.65B

Highlights
AtriCure's EPS has increased by 7% YoY
AtriCure's quick ratio has surged by 90% YoY but it has decreased by 19% QoQ
The equity has soared by 72% YoY but it has contracted by 5% from the previous quarter
ATRC's net income is down by 6% YoY

Key stats

What are the main financial stats of ATRC
Market
Shares outstanding
45.63M
Market cap
$3.66B
Enterprise value
$3.65B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
9.34
Price to sales (P/S)
16.83
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
17.15
Earnings
Revenue
$212.58M
EBIT
-$43.68M
EBITDA
-$34.46M
Free cash flow
-$17.85M
Per share
EPS
-$1.12
Free cash flow per share
-$0.4
Book value per share
$8.58
Revenue per share
$4.76
TBVPS
$7.55
Balance sheet
Total assets
$699.9M
Total liabilities
$308.66M
Debt
$73.58M
Equity
$391.24M
Working capital
$239.84M
Liquidity
Debt to equity
0.19
Current ratio
5.1
Quick ratio
4.4
Net debt/EBITDA
0.34
Margins
EBITDA margin
-16.2%
Gross margin
72.9%
Net margin
-22.9%
Operating margin
-21%
Efficiency
Return on assets
-6.9%
Return on equity
-11.9%
Return on invested capital
-14.2%
Return on capital employed
-6.8%
Return on sales
-20.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ATRC stock price

How has the AtriCure stock price performed over time
Intraday
-0.1%
1 week
3.34%
1 month
3.51%
1 year
78.2%
YTD
44.01%
QTD
1.06%

Financial performance

How have AtriCure's revenue and profit performed over time
Revenue
$212.58M
Gross profit
$154.97M
Operating income
-$44.66M
Net income
-$48.66M
Gross margin
72.9%
Net margin
-22.9%
The net margin has contracted by 15% YoY
The operating margin has declined by 12% year-on-year
ATRC's revenue is down by 8% year-on-year but it is up by 2.9% since the previous quarter
The company's gross profit fell by 8% YoY but it rose by 3.8% QoQ

Growth

What is AtriCure's growth rate over time

Valuation

What is AtriCure stock price valuation
P/E
N/A
P/B
9.34
P/S
16.83
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
17.15
AtriCure's EPS has increased by 7% YoY
ATRC's price to book (P/B) is 91% higher than its 5-year quarterly average of 4.9 and 67% higher than its last 4 quarters average of 5.6
The equity has soared by 72% YoY but it has contracted by 5% from the previous quarter
ATRC's P/S is 191% above its 5-year quarterly average of 5.8 and 59% above its last 4 quarters average of 10.6
ATRC's revenue is down by 8% year-on-year but it is up by 2.9% since the previous quarter

Efficiency

How efficient is AtriCure business performance
The ROE has grown by 37% YoY and by 9% from the previous quarter
The company's return on invested capital rose by 37% YoY and by 7% QoQ
AtriCure's return on assets has increased by 25% YoY and by 5% QoQ
AtriCure's ROS has decreased by 14% YoY

Dividends

What is ATRC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ATRC.

Financial health

How did AtriCure financials performed over time
AtriCure's total assets is 127% higher than its total liabilities
AtriCure's quick ratio has surged by 90% YoY but it has decreased by 19% QoQ
The current ratio has surged by 57% year-on-year but it has declined by 18% since the previous quarter
The debt is 81% less than the equity
The equity has soared by 72% YoY but it has contracted by 5% from the previous quarter
The debt to equity has declined by 41% year-on-year but it has grown by 6% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.